MedTrace Logo

Manganese in Women With Encephalopathy

NCT00985010 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2016-11-08

Study results available
· View outcomes & findings →

Summary

Objective:

Report manganese serum levels and mortality in encephalopathic patients.

Patients and participants:

Consecutive patients aged \> 18 years, with hepatic encephalopathy and informed consent signed by their families.

Interventions:

Patients' clinical characteristics as well as biochemical tests of renal function, hemoglobin, glucose and albumin levels were obtained as well as a blood sample to analyze manganese levels with a graphite furnace atomic absorption spectrometer.

Hypothesis:

There is a difference in the manganese levels between male and female patients.

Conditions

  • Hepatic Encephalopathy

Sponsors & Collaborators

  • Hospital General "Dr. Darío Fernández Fierro"

    collaborator UNKNOWN

  • National Institute of Neurology and Neurosurgery

    collaborator UNKNOWN

  • Materno-Perinatal Hospital of the State of Mexico

    lead OTHER

Principal Investigators

  • Hugo Mendieta Zerón, PhD · Materno-Perinatal Hospital of the State of Mexico

  • Camilo Rios Castañeda, PhD · National Institute of Neurology and Neurosurgery

  • Mónica Rodríguez Rodríguez, MD · General Hospital "Dr. Darío Fernández Fierro"

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2005-01-31
Completion
2005-01-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00985010 on ClinicalTrials.gov